ANKİLOZAN SPONDİLİTLİ HASTALARDA KİNEZYOFOBİNİN HASTALIK AKTİVİTESİ ve FONKSİYONEL DURUMA ETKİSİ

Öz

Amaç

Çalışmamızın amacı ankilozan spondilit (AS)’li hastalarda kinezyofobi düzeyinin hastalık aktivitesi, fonksiyonel durum, depresyon, yorgunluk ve yaşam kalitesi üzerine olan etkisini değerlendirmektir.

Gereç ve Yöntemler

Çalışmaya 46 (31 erkek, 15 kadın) AS’li hasta ile 40 (11 erkek, 29 kadın) sağlıklı kontrol dahil edildi. Yaşam kalitesi Sağlık Değerlendirme Anketi (SDA), hastalık aktvitesi Bath Ankilozan Spondilit Hastalık Aktivite İndexi (BASDAI), fonksiyonel durum Bath Ankilozan Spondilit Fonksiyonel İndex (BASFI), ağrı şiddeti Vizüel Analog Skala (VAS), kinezyofobi Tampa Kinezyofobi Skalası (TKS), yorgunluk VAS, depresyon Beck Depresyon Envanteri (BDE) ve fiziksel aktivite düzeyi Uluslararası Fiziksel Aktivite Anketi (UAFAA) kısa form ile değerlendirildi

Bulgular

TKS (p <0,001), VAS-ağrı (p:0,000), VAS-yorgunluk (p:0,037), SDA (p:0,000), BDE (p:0,002), BASDAI (p:0,000) ve BASFI (p:0,000) skorları AS grubunda sağlıklı kontrollere göre daha yüksekken, fiziksel aktivite düzeylerinde (p:0,412) istatistiksel açıdan anlamlı fark yoktu. AS'li hastalarda TKS skoru ile VAS-ağrı (r:0,684, p:0,000), VAS-yorgunluk (r:0,494, p:0,000), BDE (r:0,321, p:0,033), BASDAI (r:0,484, p:0,001) ve BASFI (r:0,389, p:0,008) skorları ilişkili bulundu.

Sonuç

AS’li hastalarda kinezyofobi oranları daha yüksek olup; hastalık aktivitesi, fonksiyonel durum, ağrı, yorgunluk ve depresyonla ilişkili bulunmuştur. Katastrofik düşünce ve hareket korkusu eğilimi olan AS’li hastaları önceden tespit edip, kinezyofobiyi tedavi edebilirsek AS’li hastaların nonfarmakolojik tedavisinde önemli bir ilerleme kaydedebileceğimizi düşünmekteyiz.

Anahtar Kelimeler

• Ankilozan spondilit,kinezyofobi,hareket korkusu

Kaynakça

1. 1. Pedersen SJ, Poddubnyy D, Sørensen IJ, Loft AG, Hindrup JS, Thamsborg G, et al. Course of Magnetic Resonance Imaging–Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double‐Blind, Placebo‐Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods. Arthritis & Rheumatology 2016; 68: 418-29.
2. 2. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Annals of the rheumatic diseases 2009; 68: ii1-ii44.
3. 3. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 2006; 54: 569-78.
4. 4. Wu Q, Inman RD, Davis KD. Neuropathic pain in ankylosing spondylitis: a psychophysics and brain imaging study. Arthritis & Rheumatism 2013; 65: 1494-503.
5. 5. Salaffi F, De Angelis R, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatology international 2014; 34: 1103-10.
6. 6. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. The Journal of Pain 2009; 10: 895-926.
7. 7. Kori S. Kinisophobia: a new view of chronic pain behavior. Pain Manage 1990: 35-43.
8. 8. Vlaeyen JW, Kole-Snijders AM, Boeren RG, Van Eek H. Fear of movement/(re) injury in chronic low back pain and its relation to behavioral performance. Pain 1995; 62: 363-72.

9. 9. Er G, AngIn E. Determining the relationship of kinesiophobia with respiratory functions and functional capacity in ankylosing spondylitis. Medicine 2017; 96.
10. 10. Oskay D, Tuna Z, DÜZGÜN İ, ELBASAN B, Yakut Y, Tufan A. Relationship between kinesiophobia and pain, quality of life, functional status, disease activity, mobility, and depression in patients with ankylosing spondylitis. Turkish journal of medical sciences 2017; 47: 1340-7.
11. 11. Calin A, Edmunds L, Kennedy LG. Fatigue in ankylosing spondylitis--why is it ignored? The Journal of rheumatology 1993; 20: 991-5.
12. 12. Jones S, Koh W, Steiner A, Garrett S, Calin A. Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. The Journal of rheumatology 1996; 23: 487-90.
13. 13. Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM. Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self‐reported measures. Arthritis Care & Research 2005; 53: 5-11.
14. 14. Van Tubergen A, Coenen J, Landewé R, Spoorenberg A, Chorus A, Boonen A, et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Care & Research 2002; 47: 8-16.
15. 15. Ortiz Z, Shea B, Garcia Dieguez M, Boers M, Tugwell P, Boonen A, et al. The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials. J Rheumatol 1999; 26: 210-6.
16. 16. Paul-Dauphin A, Guillemin F, Virion J-M, Briançon S. Bias and precision in visual analogue scales: a randomized controlled trial. American journal of epidemiology 1999; 150: 1117-27.
17. 17. LaChapelle DL, Finlayson M. An evaluation of subjective and objective measures of fatigue in patients with brain injury and healthy controls. Brain injury 1998; 12: 649-59.
18. 18. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of general psychiatry 1961; 4: 561-71.
19. 19. Group I. International physical activity questionnaire. 2016. Ref Type: Internet Communication 2012.
20. 20. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 1993; 36: 729-40.
21. 21. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. The Journal of rheumatology 2003; 30: 167-78.
22. 22. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. The Journal of rheumatology 1994; 21: 2286-91.
23. 23. van Weely SF, van Denderen CJ, van der Horst-Bruinsma IE, Nurmohamed MT, Dijkmans BA, Dekker J, et al. Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitis. Rheumatology 2009; 48: 1254-60.
24. 24. Kemal N, Cevik R, Bozkurt M, Ali G, Saraç AJ. Relationship between clinical findings, quality of life and functional disability related to disease activity in patients with ankylosing spondylitis. Archives of Rheumatology 2011; 26: 029-37.
25. 25. Cho H, Kim T, Kim T-H, Lee S, Lee KH. Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis. Annals of rehabilitation medicine 2013; 37: 675-82.
26. 26. Günaydin R, Karatepe AG, Çeşmeli N, Kaya T. Fatigue in patients with ankylosing spondylitis: relationships with disease-specific variables, depression, and sleep disturbance. Clinical rheumatology 2009; 28: 1045-51.
27. 27. Dernis-Labous E, Messow M, Dougados M. Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology 2003; 42: 1523-8.
28. 28. Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychological bulletin 2007; 133: 581.
29. 29. Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. Journal of behavioral medicine 2007; 30: 77-94.
30. 30. Stubbs B, Patchay S, Soundy A, Schofield P. The avoidance of activities due to fear of falling contributes to sedentary behavior among community-dwelling older adults with chronic musculoskeletal pain: a multisite observational study. Pain Medicine 2014; 15: 1861-71.
31. 31. Uthman OA, van der Windt DA, Jordan JL, Dziedzic KS, Healey EL, Peat GM, et al. Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis. Bmj 2013; 347: f5555.
32. 32. Fongen C, Halvorsen S, Dagfinrud H. High disease activity is related to low levels of physical activity in patients with ankylosing spondylitis. Clinical rheumatology 2013; 32: 1719-25.
33. 33. Fabre S, Molto A, Dadoun S, Rein C, Hudry C, Kreis S, et al. Physical activity in patients with axial spondyloarthritis: a cross-sectional study of 203 patients. Rheumatology international 2016; 36: 1711-8.
34. 34. Zhao S, Thong D, Miller N, Duffield SJ, Hughes DM, Chadwick L, et al. The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis. Arthritis research & therapy 2018; 20: 140.
35. 35. Xu X, Shen B, Zhang A, Liu J, Da Z, Liu H, et al. Anxiety and depression correlate with disease and quality-of-life parameters in Chinese patients with ankylosing spondylitis. Patient preference and adherence 2016; 10: 879.